Rchr
J-GLOBAL ID:200901077527069573   Update date: Nov. 19, 2024

Okada Futoshi

オカダ フトシ | Okada Futoshi
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://byoutaiseikagaku.jimdo.com/
Research field  (1): Experimental pathology
Research keywords  (5): AMIGO2 ,  がん転移の機構解析と予防開発 ,  発癌・悪性化進展機構 ,  炎症発がん ,  がん予防
Research theme for competitive and other funds  (47):
  • 2023 - 2026 Role of AMIGO2 in acquisition of cancer stem cell properties and identification of inhibitory compounds
  • 2022 - 2024 Verification of active sulfur species in inflammation-related carcinogenesis
  • 2020 - 2023 Determination of liver metastasis preventive compounds targeting Amigo2 molecule for extrapolation to humans
  • 2017 - 2020 Role of cystine/glutamate transporter in cancer metastasis.
  • 2017 - 2020 Determining the driver gene for colon carcinogenesis accelerated by chronic inflammation
Show all
Papers (163):
  • HeeKyung Seong, Yusuke Kanda, Runa Izutsu, Jumond P Jehung, Junichi Hamada, Mitsuhiko Osaki, Koji Okamoto, Futoshi Okada. Prevention of liver metastasis via the pharmacological suppression of AMIGO2 expression in tumor cells. Scientific reports. 2024. 14. 1. 28183-28183
  • Runa Izutsu, Mitsuhiko Osaki, HeeKyung Seong, Sanami Ogata, Reo Sato, Jun-Ichi Hamada, Futoshi Okada. AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMT. Cancer gene therapy. 2024
  • Yuki Iida, Mitsuhiko Osaki, Shinya Sato, Runa Izutsu, HeeKyung Seong, Hiroaki Komatsu, Fuminori Taniguchi, Futoshi Okada. AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells. International Journal of Clinical Oncology. 2024. 29. 9. 1354-1363
  • Masahiro Makinoya, Kozo Miyatani, Yoshiaki Matsumi, Yu Sakano, Shota Shimizu, Yuji Shishido, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, et al. Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis. Scientific Reports. 2024. 14. 1
  • Ai Ikebuchi, Mitsuhiko Osaki, Ikumi Wada, Hiroki Nagata, Kei Nagira, Yukihiro Azuma, Futoshi Okada, Tasuku Harada, Fuminori Taniguchi. Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis. Journal of gynecology obstetrics and human reproduction. 2023. 52. 9. 102645-102645
more...
MISC (320):
  • 井筒 瑠奈, 尾崎 充彦, ソン・ヒギョン, 岡田 太. ヒト胃癌細胞由来AMIGO2包含エクソソームは肝微小環境に作用し前転移ニッチェを形成する. 日本病理学会会誌. 2023. 112. 1. 238-238
  • Seong Heekyung, 井筒 瑠奈, 尾崎 充彦, 岡田 太. AMIGO2発現によるヒト癌細胞の癌幹細胞様形質の制御. 日本病理学会会誌. 2023. 112. 1. 314-314
  • Is lysosome-associated membrane protein-2 expression involved in sunitinib resistance in human renal cell carcinoma?. 2021. 81. 増刊. 136-136
  • 岡田 太. がん予防研究と今後の展開 実験的炎症発がんモデルから考えるがん予防. 電気泳動. 2021. 65. Suppl. s19-s19
  • 井筒 瑠奈, 鄭 朱蒙パトリック, 根本 英幸, 石川 瑞穂, 尾崎 充彦, 岡田 太. ヒト胃癌細胞が分泌するAmigo2包含エクソソームは、胃癌細胞と肝内皮細胞との接着能を亢進させる. 日本病理学会会誌. 2021. 110. 1. 373-373
more...
Patents (8):
Books (1):
  • 一般がんの発癌要因としての低酸素・再酸素化の証明
    [岡田太] 2007
Work history (1):
  • 2010/04 - 現在 Tottori University Division of Experimental Pathology, Faculty of Medicine Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page